MOORESVILLE, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, one of America’s leading hemp brands, announces the launch of its Fresh Bloom THCA Flower Subscription Box —delivering a curated ...
Hasan Shahid is the Founder and Chief Investment Officer of League Capital, a New York–based hedge fund specializing in technology, artificial intelligence, digital assets, and alternative investment ...
(NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral nerve function, today announced that the U.S. Food and Drug ...
Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) ...
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced its participation at the ...
The Company intends to use the net proceeds from the Offering primarily for development activities, including the completion of its pivotal trial, and preparation of the PMA submission for GerlinC, ...
The Phase 1 ragistomig study achieved its objective, as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders, with an improved safety profile The interim ...
Company to host a conference call and webcast on Saturday, December 6, 2025, at 8:00 pm ET ...
TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...
Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of t ...
– Fourth quarter fiscal 2025 revenue up 5.9% to $138.1 million – Fiscal 2025 revenue increased 4.5% to $513.0 million – Fourth quarter fiscal 2025 operating loss decreased 48.5% to $6.8 million – ...
LAKEWOOD, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2026 at approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback